Concert Pharmaceuticals has received US patent for CTP-499, its drug candidate being developed for the treatment of diabetic nephropathy. CTP-499 is a potential treatment developed on the basis of DCE Platform for diabetic nephropathy, a ...
The European Commission (EC) has granted orphan drug designation to Sunesis Pharmaceuticals' Vosaroxin drug. Vosaroxin is a first-in-class anti-cancer quinolone derivative, (AQD), used for the treatment of acute myeloid leukemia (AML). ...
Tags: vosaroxin, AQD, AML, anti-cancer quinolone derivative
IDG News Service-Apple and Samsung will return on Thursday to the San Jose courtroom where they battled over cell phone patents earlier this year,and Apple subsequently won damages of$1.05 billion. The late August trial saw both companies ...
Tags: Apple, Samsung, cell phone patents, iPhone
NewLink Genetics has received a notice of allowance for a Japanese patent entitled, Antitumor Vaccination Using Allogeneic Tumor Cells Expressing Alpha (1,3)-Galactosyltransferase. The patent contains pharmaceutical composition claims ...
Tags: NewLink Genetics, galactosyltransferase, antitumor vaccination
US based Watson Pharmaceuticals has filed a legal case against US Food and Drug Administration's (FDA) decision regarding the company's exclusivity for its generic version of Actos (Pioglitazone Hydrochloride 15mg, 30mg and 45mg tablets). ...
Tags: Watson Pharmaceuticals, Actos, Pioglitazone Hydrochloride
The Australian Patent Office and the patent office of Mexico, Instituto Mexicano de la Propiedad Industrial, have granted new patents to Quick-Med Technologies' polyurethane-modified polycation, a new product of the NIMBUS technology family ...
Tags: patent, polyurethane modified polycation, antimicrobial
America's Impax Laboratories has begun the challenging process against the suit filed by two companies for patent infringement over a generic version of Opana® ER (oxymorphone hydrochloride extended-release) drug. Impax ...
Roche has entered into a collaboration agreement to integrate Elsevier's Reaxys workflow solution into its propriety reaction information to improve productivity and benefit from increased discoverability of in-house chemistry content as ...
Tags: Roche, Reaxys workflow solution, integrated chemistry data
7th Business Sourcing Event of Made-in-China.com was held in Guangzhou Westin Hotel successfully on April 18, 2012. During every Canton Fair, Made-in-China.com helps China suppliers and global buyers to contact each other with the form of ...
Tags: Sourcing Event, Sourcing
Israel-based nutraceutical ingredients company LycoRed has announced that it has witnessed high sales growth of its natural tomato complex Lyc-O-Mato in Japan over the past few years, and plans to hold a seminar to discuss its latest ...
Tags: natural tomato complex Lyc-O-Mato, latest finding on the complex
Soho Flordis International,a US-based manufacturer and provider of health medicines,has announced that it has patented its fat binding complexor,FBCx,which will be available as an ingredient The new FBCx will enable people to lose about 5 ...
Global innovation leader Milliken & Company announced that the company has opened a regional headquarters in Shanghai. Leveraging its long presence in the region, Milliken’s new Asia headquarters combines sales, marketing, design, ...
Tags: combines sales, Milliken Company, floor covering design studio
Bend Research has won two new US patents covering the technology that increases the oral bioavailability of low-solubility drugs. The patents protect compositions and processes for making spray-dried dispersions (SDDs) made with an ...
Tags: patent, pharmaceutical technology, low-solubility drug
Scott White, an inventor of a condiment container called the CondiCup, has filed a lawsuit alleging patent infringement by Heinz. According to White, the ketchup company infringed one or more patents through its 'Dip & Squeeze' product. ...
Tags: Ketchup Packaging, Squeeze ketchup package, condiment container
Astellas Pharma and Tokyo Institute of Technology have announced a joint research agreement for drug discovery research leveraging Tokyo-Tech's TSUBAME2.0 supercomputer to discover candidates for the treatment of diseases caused by ...